| Particulars |
| Company Name |
Cohance Lifesciences Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
38.26 |
B.V. Rs |
115.30 |
| Sales Rs Cr. |
1,093.51 |
NP Rs Cr. |
271.77 |
| NP Var% |
-8.00 |
Div% |
0.00 |
| CPS Rs |
8.60 |
EPS Rs |
7.10 |
| Traded Value(Rs Lakhs) |
422.40 |
52 Week High |
1,328.00 |
| 52 Week Low |
488.00 |
Price BSE |
492.00 |
| Price NSE |
493.00 |
Market Capital(Rs Cr.) |
18,839.52 |
| P/C Ratio |
57.20 |
P/E Ratio |
69.30 |
| Price Vs.BV |
4.27 |
|
| Latest Quarter |
| Year End |
202509 |
Sales Rs Cr. |
497.79 |
| NP Rs Cr. |
94.29 |
NP Var % |
-32.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
914.50 |
| OPM |
38.18 |
NP |
247.20 |
| NP Var% |
15.89 |
EPS |
9.70 |
| PE |
50.77 |
|
|